DE602004006997D1 - 4-(aminomethyl)-piperidinbenzamide als 5ht4 -antagonisten - Google Patents

4-(aminomethyl)-piperidinbenzamide als 5ht4 -antagonisten

Info

Publication number: DE602004006997D1
Authority: DE; Germany
Prior art keywords: piperidinbenzamides; aminomethyl; antagonists
Prior art date: 2003-06-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE602004006997T

Other languages

English (en)

Other versions

DE602004006997T2 (de

Inventor

Jean-Paul Rene Marie A Bosmans

Henricus Jacobus Mari Gijsen

Laurence Anne Mevellec

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Pharmaceutica NV

Original Assignee

Janssen Pharmaceutica NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-19

Filing date

2004-06-10

Publication date

2007-07-26

2004-06-10 Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV

2007-07-26 Publication of DE602004006997D1 publication Critical patent/DE602004006997D1/de

2008-05-15 Application granted granted Critical

2008-05-15 Publication of DE602004006997T2 publication Critical patent/DE602004006997T2/de

2024-06-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Cardiology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

DE602004006997T 2003-06-19 2004-06-10 4-(aminomethyl)-piperidinbenzamide als 5ht4 -antagonisten Expired - Lifetime DE602004006997T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP0350236		2003-06-19
WOPCT/EP03/50236		2003-06-19
PCT/EP2004/006285 WO2005000838A1 (en)	2003-06-19	2004-06-10	4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists

Publications (2)

Publication Number	Publication Date
DE602004006997D1 true DE602004006997D1 (de)	2007-07-26
DE602004006997T2 DE602004006997T2 (de)	2008-05-15

Family

ID=33547568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602004006997T Expired - Lifetime DE602004006997T2 (de)	2003-06-19	2004-06-10	4-(aminomethyl)-piperidinbenzamide als 5ht4 -antagonisten

Country Status (28)

Country	Link
US (1)	US7638535B2 (de)
EP (1)	EP1641784B1 (de)
JP (1)	JP4688800B2 (de)
KR (1)	KR101151645B1 (de)
CN (1)	CN100537565C (de)
AR (1)	AR044821A1 (de)
AT (1)	ATE364602T1 (de)
AU (1)	AU2004251825B2 (de)
BR (1)	BRPI0411603B1 (de)
CA (1)	CA2528590C (de)
CY (1)	CY1106857T1 (de)
DE (1)	DE602004006997T2 (de)
DK (1)	DK1641784T3 (de)
EA (1)	EA008504B1 (de)
ES (1)	ES2288258T3 (de)
HR (1)	HRP20070393T3 (de)
IL (1)	IL172604A (de)
JO (1)	JO2478B1 (de)
MX (1)	MXPA05013772A (de)
MY (1)	MY139454A (de)
NZ (1)	NZ544592A (de)
PA (1)	PA8605101A1 (de)
PL (1)	PL1641784T3 (de)
PT (1)	PT1641784E (de)
SI (1)	SI1641784T1 (de)
TW (1)	TWI346107B (de)
UA (1)	UA88607C2 (de)
WO (1)	WO2005000838A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200533348A (en)	2004-02-18	2005-10-16	Theravance Inc	Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en)	2004-04-07	2010-06-01	Theravance, Inc.	Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en)	2004-04-07	2011-11-01	Theravance Inc	Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en)	2004-04-07	2012-11-13	Theravance, Inc.	Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
ATE441646T1 (de)	2004-11-05	2009-09-15	Theravance Inc	5-ht4-rezeptoragonistenverbindungen
JP5042028B2 (ja)	2004-11-05	2012-10-03	セラヴァンス，インコーポレーテッド	キノリノン−カルボキサミド化合物
CA2588037A1 (en)	2004-12-22	2006-06-29	Theravance, Inc.	Indazole-carboxamide compounds
US7446114B2 (en)	2005-03-02	2008-11-04	Theravance, Inc.	Quinolinone compounds as 5-HT4 receptor agonists
US9101160B2 (en)	2005-11-23	2015-08-11	The Coca-Cola Company	Condiments with high-potency sweetener
US8017168B2 (en)	2006-11-02	2011-09-13	The Coca-Cola Company	High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20100081981A1 (en) *	2008-10-01	2010-04-01	Cheng Shien-Che	Wrist support
GB0901487D0 (en) *	2009-01-30	2009-03-11	Movetis N V	Asthma Therapy
US9029368B2 (en)	2011-11-30	2015-05-12	Actelion Pharmaceuticals Ltd.	3,7-disubstituted octahydro-2H-pyrido[4,3-E][1,3]oxazin-2-one antibiotics
GB201403093D0 (en)	2014-02-21	2014-04-09	Cancer Rec Tech Ltd	Therapeutic compounds and their use
EP3404023A4 (de)	2016-01-15	2019-11-13	Sumitomo Dainippon Pharma Co., Ltd.	Biheterocyclische verbindung
GB201715194D0 (en)	2017-09-20	2017-11-01	Carrick Therapeutics Ltd	Compounds and their therapeutic use
GB201918541D0 (en)	2019-12-16	2020-01-29	Carrick Therapeutics Ltd	Therapeutic compounds and their use
CN115974856B (zh) *	2022-12-28	2023-08-11	北京康立生医药技术开发有限公司	一种治疗成人t细胞白血病淋巴瘤药物伐美妥司他的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4186135A (en) *	1976-08-04	1980-01-29	Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France	Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
US5374637A (en) *	1989-03-22	1994-12-20	Janssen Pharmaceutica N.V.	N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
HUT70154A (en) *	1991-09-12	1995-09-28	Smithkline Beecham Plc	5-ht4 receptor antagonists and pharmaceutical compositions containing them
JPH07503480A (ja) *	1992-02-06	1995-04-13	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	５−ｈｔ４拮抗薬としてのベンゾピラン，ベンゾチオピランおよびベンゾフラン誘導体
TW402591B (en) *	1997-07-11	2000-08-21	Janssen Pharmaceutica Nv	Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
TW570920B (en) *	1998-12-22	2004-01-11	Janssen Pharmaceutica Nv	4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders

2004
- 2004-06-09 JO JO200473A patent/JO2478B1/en active
- 2004-06-10 CA CA2528590A patent/CA2528590C/en not_active Expired - Fee Related
- 2004-06-10 JP JP2006515886A patent/JP4688800B2/ja not_active Expired - Fee Related
- 2004-06-10 BR BRPI0411603-8A patent/BRPI0411603B1/pt not_active IP Right Cessation
- 2004-06-10 NZ NZ544592A patent/NZ544592A/en not_active IP Right Cessation
- 2004-06-10 DK DK04739785T patent/DK1641784T3/da active
- 2004-06-10 AU AU2004251825A patent/AU2004251825B2/en not_active Ceased
- 2004-06-10 HR HR20070393T patent/HRP20070393T3/xx unknown
- 2004-06-10 WO PCT/EP2004/006285 patent/WO2005000838A1/en not_active Ceased
- 2004-06-10 PT PT04739785T patent/PT1641784E/pt unknown
- 2004-06-10 US US10/560,479 patent/US7638535B2/en not_active Expired - Fee Related
- 2004-06-10 EP EP04739785A patent/EP1641784B1/de not_active Expired - Lifetime
- 2004-06-10 PL PL04739785T patent/PL1641784T3/pl unknown
- 2004-06-10 DE DE602004006997T patent/DE602004006997T2/de not_active Expired - Lifetime
- 2004-06-10 ES ES04739785T patent/ES2288258T3/es not_active Expired - Lifetime
- 2004-06-10 EA EA200600061A patent/EA008504B1/ru not_active IP Right Cessation
- 2004-06-10 SI SI200430410T patent/SI1641784T1/sl unknown
- 2004-06-10 CN CNB2004800171349A patent/CN100537565C/zh not_active Expired - Fee Related
- 2004-06-10 AT AT04739785T patent/ATE364602T1/de active
- 2004-06-10 MX MXPA05013772A patent/MXPA05013772A/es active IP Right Grant
- 2004-06-15 PA PA20048605101A patent/PA8605101A1/es unknown
- 2004-06-16 MY MYPI20042307A patent/MY139454A/en unknown
- 2004-06-18 AR ARP040102131A patent/AR044821A1/es active IP Right Grant
- 2004-06-18 TW TW093117573A patent/TWI346107B/zh not_active IP Right Cessation
- 2004-10-06 UA UAA200511028A patent/UA88607C2/ru unknown
2005
- 2005-12-10 KR KR1020057023794A patent/KR101151645B1/ko not_active Expired - Fee Related
- 2005-12-15 IL IL172604A patent/IL172604A/en active IP Right Grant
2007
- 2007-09-11 CY CY20071101169T patent/CY1106857T1/el unknown

Also Published As

Publication number	Publication date
EA008504B1 (ru)	2007-06-29
IL172604A0 (en)	2006-04-10
KR101151645B1 (ko)	2012-06-08
UA88607C2 (en)	2009-11-10
CN100537565C (zh)	2009-09-09
CA2528590A1 (en)	2005-01-06
NZ544592A (en)	2008-05-30
JO2478B1 (en)	2009-01-20
DE602004006997T2 (de)	2008-05-15
ES2288258T3 (es)	2008-01-01
CA2528590C (en)	2012-04-03
EP1641784A1 (de)	2006-04-05
KR20060018263A (ko)	2006-02-28
PL1641784T3 (pl)	2007-11-30
HRP20070393T3 (en)	2007-10-31
US7638535B2 (en)	2009-12-29
US20060281753A1 (en)	2006-12-14
AU2004251825A1 (en)	2005-01-06
ATE364602T1 (de)	2007-07-15
WO2005000838A1 (en)	2005-01-06
AR044821A1 (es)	2005-10-05
PA8605101A1 (es)	2005-02-04
IL172604A (en)	2010-12-30
MY139454A (en)	2009-10-30
CY1106857T1 (el)	2012-05-23
PT1641784E (pt)	2007-08-28
TW200517376A (en)	2005-06-01
AU2004251825B2 (en)	2009-11-26
DK1641784T3 (da)	2007-09-24
BRPI0411603B1 (pt)	2017-10-31
EP1641784B1 (de)	2007-06-13
JP2006527716A (ja)	2006-12-07
TWI346107B (en)	2011-08-01
EA200600061A1 (ru)	2006-06-30
CN1809558A (zh)	2006-07-26
HK1095327A1 (zh)	2007-05-04
SI1641784T1 (sl)	2007-10-31
MXPA05013772A (es)	2006-03-08
JP4688800B2 (ja)	2011-05-25
BRPI0411603A (pt)	2006-08-08

Publication	Publication Date	Title
DE50304983D1 (de)	2006-10-19	Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
DE60330694D1 (de)	2010-02-04	Pyrimidopyrimidone als kinaseinhibitoren
ATE525377T1 (de)	2011-10-15	Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase
SE0302305D0 (sv)	2003-08-27	Novel Compounds
DE602004015724D1 (de)	2008-09-25	Diazepinoindolderivate als kinaseinhibitoren
ATE414693T1 (de)	2008-12-15	Neuartige cis-imidazoline
DE602004018654D1 (de)	2009-02-05	Se
DE602004024420D1 (de)	2010-01-14	Chinazolinderivate als antitumormittel
IS8108A (is)	2005-10-31	Ný efnasambönd
ATE401893T1 (de)	2008-08-15	Thiophenepyrimidinone als 17-beta-hydroxysteroid dehydrogenase inhibitoren
DE602004006997D1 (de)	2007-07-26	4-(aminomethyl)-piperidinbenzamide als 5ht4 -antagonisten
IS8228A (is)	2006-01-11	Ný asetídínefnasambönd
DE602004004295D1 (de)	2007-02-22	6-ä(substituiertes)phenylütriazolopyrimidine als antikrebsmittel
ATE394372T1 (de)	2008-05-15	G-lactamderivate als prostaglandinagonisten
IS8292A (is)	2006-02-09	Ný efnasambönd
DK1633719T3 (da)	2010-01-04	Substituerede spirobenzazepiner
DE502004005570D1 (de)	2008-01-03	Mousepad
SE0402103D0 (sv)	2004-08-30	Novel compounds
FIU20030123U0 (fi)	2003-03-28	Hiirimatto
SE0300118D0 (sv)	2003-01-17	Novel Compounds
SE0302667D0 (sv)	2003-10-07	Novel Compounds
SE0300388D0 (sv)	2003-02-12	Novel compounds
SE0301733D0 (sv)	2003-06-16	Vindskydd
SE0301738D0 (sv)	2003-06-13	Ellist
SE0401885D0 (sv)	2004-07-19	Novel compounds

Legal Events

Date	Code	Title	Description
2008-07-03	8364	No opposition during term of opposition